Landos Biopharma, Inc. 8-K SEC Filings

Filed On	Filing
23 May 2024	8-K: Completion of Acquisition or Disposition of Assets; Notice of Delisting or Failure to Satisfy a Listing Rule +5 more
23 May 2024	8-K: Submission of Matters to a Vote of Security Holders
25 Mar 2024	8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
21 Mar 2024	8-K: Results of Operations and Financial Condition
04 Jan 2024	8-K: Regulation FD Disclosure
21 Nov 2023	8-K: Regulation FD Disclosure
09 Nov 2023	8-K: Results of Operations and Financial Condition
21 Sep 2023	8-K: Departure/Election of Directors or Officers; Compensation
14 Sep 2023	8-K: Regulation FD Disclosure
09 Aug 2023	8-K: Results of Operations and Financial Condition
30 May 2023	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
25 May 2023	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders +1 more
12 May 2023	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
23 Mar 2023	8-K: Results of Operations and Financial Condition
10 Mar 2023	8-K: Other Events
28 Feb 2023	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
13 Jan 2023	8-K: Entry into a Material Definitive Agreement
05 Jan 2023	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
05 Jan 2023	8-K: Regulation FD Disclosure
16 Dec 2022	8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

Comments